Surgery in the context of kinase inhibitor therapy for locally invasive thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surgery in the context of kinase inhibitor therapy for locally invasive thyroid cancer

Published:2020-04 Issue:4 Volume:46 Page:650-655
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Hartl Dana M.,Guerlain Joanne,Bresuskin Ingrid,Baudin Eric,Lamartina Livia,Hadoux Julien,Leboulleux Sophie,Schlumberger Martin

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference42 articles.

1. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;N Engl J Med,2015

2. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial;Wells;J Clin Oncol : Off J Am Soc Clin Oncol,2012

3. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer;Subbiah;J Clin Oncol : official journal of the American Society of Clinical Oncology,2018

4. Immune-related thyroiditis with immune checkpoint inhibitors;Iyer;Thyroid : official journal of the American Thyroid Association,2018

5. Neoadjuvant BRAF- and immune-directed therapy for anaplastic thyroid carcinoma;Cabanillas;Thyroid : official journal of the American Thyroid Association.,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and verification of the first prognostic nomograms in locally advanced thyroid cancer based on the analysis of clinical and follow-up information on 2396 patients;Heliyon;2024-02

2. Recurrent Differentiated Thyroid Cancer: The Current Treatment Options;Cancers;2023-05-10

3. Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer;Head & Neck;2022-12-16

4. Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia;Advances in Therapy;2021-10-21

5. Current practice in patients with differentiated thyroid cancer;Nature Reviews Endocrinology;2020-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3